Pasithea Therapeutics Corp. Gains 48.15%
Thu, Apr 10, 2025 at 07:59 PM
Pasithea Therapeutics Corp. (KTTA:NASDAQ) shot up at $1.6, representing a gain of 48.1%. On Thu, Apr 10, 2025, KTTA:NASDAQ hit a New 2-Week High of $1.6. The stock appeared on our News Catalysts scanner on Thu, Apr 10, 2025 at 10:13 AM in the 'BIOTECH' category. From Thu, Mar 27, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Apr 10, 2025 at $2.34 with a volume of 101M+.
About Pasithea Therapeutics Corp. (KTTA:NASDAQ)
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Top 10 Gainers:
- Innovative Eyewear Inc. (LUCY:NASDAQ), 104.55%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 72.58%
- Janover Inc. (JNVR:NASDAQ), 64.24%
- MEDIROM Healthcare Technologies Inc. (MRM:NASDAQ), 56.25%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 48.15%
- Bionano Genomics, Inc. (BNGO:NASDAQ), 42.86%
- Sky Quarry Inc. (SKYQ:NASDAQ), 33.27%
- Sharps Technology Inc. (STSS:NASDAQ), 30.71%
- Wellchange Holdings Company Limited (WCT:NASDAQ), 28.38%